Our vision is to deliver a new brand of targeted medicines that will revolutionize healthcare
A new approach to fighting cancer and inflammatory disease
Demand
Design
Discovery
Development
Delivery
D5Pharma’s next-generation screening technique allows us to identify DNA aptamers that have functional characteristics specific to critical therapeutic targets
Read more about our unique approach in these academic publications
The IgV-like N domain of CEA plays a critical role in the implantation of metastatic tumor cells
Our findings point to the importance of a specific region of CEA in cancer progression.
Vaccination with MetVax prevents tumor colonization and the spread of disease.
D5’s scientists have shown that MetVax can actively prevent tumor implantation.
PEG:CCS13 is a potent DNA-based immunosuppressant.
D5Pharma’s most recent publication on PEG:CCS13: Prodeus, et al., Molecular Therapy Nucleic Acids (2018) 12, 350.